Education
About Us
Working with TipRanks
Follow Us
HABA Laboratories, Inc. (JP:4925)
:4925
RESEARCH TOOLSreports
4925 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,500.00 - ¥2,050.00
Previous CloseN/A
Volume6.60K
Average Volume (3M)843.00
Market Cap
¥6.51B
Enterprise Value¥6.03B
Total Cash (Recent Filing)¥4.01B
Total Debt (Recent Filing)¥2.11B
Price to Earnings (P/E)11.3
Beta0.27
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield2.32%
Share Statistics
EPS (TTM)94.05
Shares Outstanding3,935,000
10 Day Avg. Volume820
30 Day Avg. Volume843
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)0.82
Price to Sales (P/S)0.00
P/FCF Ratio-37.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.09%
Mutual Funds
― Other Institutional Investors
99.91% Public Companies and
Individual Investors
4925 FAQ
What was HABA Laboratories, Inc.’s price range in the past 12 months?
HABA Laboratories, Inc. lowest stock price was ¥1500.00 and its highest was ¥2050.00 in the past 12 months.
What is HABA Laboratories, Inc.’s market cap?
HABA Laboratories, Inc.’s market cap is ¥6.51B.
When is HABA Laboratories, Inc.’s upcoming earnings report date?
HABA Laboratories, Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 54 days.
How were HABA Laboratories, Inc.’s earnings last quarter?
HABA Laboratories, Inc. released its earnings results on May 09, 2025. The company reported ¥94.05 earnings per share for the quarter, beating the consensus estimate of N/A by ¥94.05.
Is HABA Laboratories, Inc. overvalued?
According to Wall Street analysts HABA Laboratories, Inc.’s price is currently Overvalued.
Does HABA Laboratories, Inc. pay dividends?
HABA Laboratories, Inc. pays a Annually dividend of ¥40 which represents an annual dividend yield of 2.32%. See more information on HABA Laboratories, Inc. dividends here
What is HABA Laboratories, Inc.’s EPS estimate?
HABA Laboratories, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HABA Laboratories, Inc. have?
HABA Laboratories, Inc. has 3,935,000 shares outstanding.
What happened to HABA Laboratories, Inc.’s price movement after its last earnings report?
HABA Laboratories, Inc. reported an EPS of ¥94.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.506%.
Which hedge fund is a major shareholder of HABA Laboratories, Inc.?
Currently, no hedge funds are holding shares in JP:4925
Company Description
HABA Laboratories, Inc.
HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products comprise shampoos, conditioners, soaps, and hair and hand treatment products. The company sells its products through mail order, shops, drug/variety stores, and internet. It has approximately 70 HABA shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was founded in 1983 and is headquartered in Tokyo, Japan.
Technical Analysis
C'BON COSMETICS Co., Ltd.
―
ADJUVANT HOLDINGS CO., LTD.
―
Almado, Inc.
―
Premier Anti-Aging Co., Ltd.
―
AXXZIA, Inc.
―